Review
Management of patients with the Zollinger-Ellison syndrome
Affiliations
- PMID: 7901311
Item in Clipboard
Review
Management of patients with the Zollinger-Ellison syndrome
J Ky Med Assoc.
1993 Sep.
Abstract
The Zollinger-Ellison syndrome, which is due to the secretion of gastrin from non-beta islet cell tumors of the pancreas, results in gastric hypersecretion and severe peptic ulcer disease. In the 1970s H2 blockers became the mainstay of therapy. More recent evidence indicates that early surgical intervention aimed at tumor extirpation results in improved outcome. The purpose of this paper is to report the case histories of three patients with Zollinger-Ellison syndrome and to review the current literature on management of patients with this syndrome.
Similar articles
-
[Treatment of Zollinger-Ellison syndrome].Harefuah. 1991 Apr 1;120(7):384-5. Harefuah. 1991. PMID: 1679028 Hebrew.
-
Resection of gastrinoma in the Zollinger-Ellison syndrome.Gastroenterology. 1982 May;82(5 Pt 1):953-6. Gastroenterology. 1982. PMID: 7060915
-
Management of the Zollinger-Ellison syndrome in patients with multiple endocrine neoplasia type I.Surgery. 1986 Dec;100(6):971-7. Surgery. 1986. PMID: 2878499
-
Case presentation of gastrinoma combined with gastric carcinoid with the longest survival record -- Zollinger-Ellison syndrome: pathophysiology, diagnosis and therapy.Med Sci Monit. 2002 Jun;8(6):CS43-59. Med Sci Monit. 2002. PMID: 12070442 Review.
-
[Treatment of patients with gastrin-producing tumors (Zollinger-Ellison syndrome)].Vopr Onkol. 1984;30(9):14-20. Vopr Onkol. 1984. PMID: 6149652 Review. Russian. No abstract available.